These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The dexamethasone suppression test in adolescent psychiatric inpatients. Targum SD; Capodanno AE Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588 [TBL] [Abstract][Full Text] [Related]
6. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings. Maes M; De Ruyter M; Suy E Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075 [TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone. Arana GW; Reichlin S; Workman R; Haaser R; Shader RI Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557 [TBL] [Abstract][Full Text] [Related]
8. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667 [TBL] [Abstract][Full Text] [Related]
9. The overnight dexamethasone suppression test: clinical and theoretical review. Gwirtsman H; Gerner RH; Sternbach H J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505 [TBL] [Abstract][Full Text] [Related]
10. The dexamethasone suppression test in adolescent psychiatric patients. Ha H; Kaplan S; Foley C Am J Psychiatry; 1984 Mar; 141(3):421-3. PubMed ID: 6703110 [TBL] [Abstract][Full Text] [Related]
11. The dexamethasone suppression test and mood following stroke. Lipsey JR; Robinson RG; Pearlson GD; Rao K; Price TR Am J Psychiatry; 1985 Mar; 142(3):318-23. PubMed ID: 3970268 [TBL] [Abstract][Full Text] [Related]
12. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia. Clower CG J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330 [TBL] [Abstract][Full Text] [Related]
13. Depression, negative and positive symptoms, and the DST in schizophrenia. Minas IH; Jackson HJ; Joshua SD; Burgess PM Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337 [TBL] [Abstract][Full Text] [Related]
14. Platelet MAO activity and the dexamethasone suppression test in depressed patients. Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the dexamethasone suppression test and the cortisol suppression index. Goggans FC; Wilson WR; Gold MS; Pottash AL Am J Psychiatry; 1984 May; 141(5):698-700. PubMed ID: 6711695 [TBL] [Abstract][Full Text] [Related]
16. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113 [No Abstract] [Full Text] [Related]
17. Effect of hospital admission on DST results. Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG Am J Psychiatry; 1984 Aug; 141(8):982-5. PubMed ID: 6465376 [TBL] [Abstract][Full Text] [Related]
18. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment. Dratcu L; Calil HM Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868 [TBL] [Abstract][Full Text] [Related]